DSpace logo

  1. BITS Pilani Institutional Repository
  2. BITS Faculty Publications
  3. Department of Pharmacy
Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13928
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKhare, Pragyanshu-
dc.date.accessioned2024-01-23T09:17:17Z-
dc.date.available2024-01-23T09:17:17Z-
dc.date.issued2015-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/B9780124200241000035-
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13928-
dc.description.abstractThe transient receptor potential vanilloid 1 (TRPV1) is a nonselective cation channel with high calcium permeability that has been studied extensively since its identification and characterization in 1997. Its involvement in different modalities of pain has been well documented, which has resulted in the development of novel strategies for the treatment of pain. However, TRPV1 is also involved in a plethora of other physiological and pathophysiological functions related to urinary, cardiovascular, gastrointestinal, respiratory, and central nervous systems. Here, we summarize the recent developments of the role of TRPV1 in acquired diseases and review the current perspective of TRPV1 agonist and antagonist as potential drugs for therapeutic intervention.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectPharmacyen_US
dc.subjectTRPV1en_US
dc.subjectNociceptorsen_US
dc.subjectInflammatory mediatorsen_US
dc.subjectPainen_US
dc.subjectCGRPen_US
dc.subjectCalciumen_US
dc.titleThe Role of TRPV1 in Acquired Diseases: Therapeutic Potential of TRPV1 Modulatorsen_US
dc.typeArticleen_US
Appears in Collections:Department of Pharmacy

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.